PROJECT SUMMARY
Accurate assessment of healthcare workers’ personal exposure to airborne pathogenic viruses
is hampered by existing bioaerosol samplers, which are either inefficient in sampling infectious
airborne viruses and maintaining their viability, or not suitable for personal sampling. The goal of
this proposed work is to more accurately assess personal exposure resulting from different
transmission modes of airborne infectious viruses. This will be accomplished by empowering the
National Institute for Occupational Safety and Health (NIOSH) bioaerosol sampler to be the
personal sampler of choice so that it can efficiently collect airborne virus-containing particles by
their particle size and maintain their viability information for exposure risk assessment.
The two specific aims of this proposal are to: (1) Calibrate the NIOSH sampler against the gold-
standard reference of Viable Virus Aerosol Sampler (VIVAS). The VIVAS is highly efficient in
collecting viable airborne viruses, but too large and heavy for personal sampling. The calibration
will be conducted using lab-generated respiratory virus aerosols to obtain correction factors for
determining viable virus aerosol concentrations using the NIOSH sampler. (2) Evaluate personal
exposures of healthcare workers to airborne viruses using the calibrated NIOSH sampler. Field
tests of co-located NIOSH sampler and the VIVAS at a student health care center (SHCC) will
corroborate the lab-generated correction factors in a real-world environment. Sampling will then
be conducted using the calibrated NIOSH sampler to assess the personal exposures of the
receptionist, healthcare providers, and medical assistants at the SHCC during flu season.
Results of the size-fractionated virus-containing particles collected by different stages of the
NIOSH sampler will bring to light the relative importance of the different transmission modes of
airborne viruses. Paired comparisons of the personal vs. stationary samplings will reveal if
stationary sampling can substitute for personal sampling. Knowledge learned from the proposed
study will allow setting of administrative polices and engineering control that better protect
healthcare workers from undesired exposure to airborne infectious viruses. This proposal
responds to two goals set by NIOSH’s Strategic Plans for FY 2019-23 that best represent the
health and safety issues facing the U.S. workforce: Goal 3 - reduce occupational infectious
disease, and Goal 5 - reduce occupational respiratory disease. Specifically, Goal 3.3 - infectious
disease transmission, and Activity Goal 3.3.1 - conduct basic/ etiologic research to better
understand influenza aerobiology and transmission in healthcare settings.
Public Health Relevance Statement
PROJECT NARRATIVE
Accurate risk assessments of personal inhalation exposures of healthcare workers to airborne
pathogenic viruses are hampered by the inability of existing personal samplers to efficiently
collect airborne viruses and maintain their viability (i.e., to keep them “alive”). Successful
development of the proposed approach will create a powerful tool, not available before, for
accurate assessments of exposure to airborne pathogenic viruses and improve our knowledge
of their transmission. Such knowledge will allow the setting of administrative policies and
technological measures that can better protect healthcare workers as well as patients from
exposure to airborne infectious viruses in healthcare facilities.
National Institute for Occupational Safety and Health
CFDA Code
262
DUNS Number
969663814
UEI
NNFQH1JAPEP3
Project Start Date
01-September-2021
Project End Date
31-August-2023
Budget Start Date
01-September-2021
Budget End Date
31-August-2022
Project Funding Information for 2021
Total Funding
$188,872
Direct Costs
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2021
National Center for Immunization and Respiratory Diseases
$188,872
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R21OH012114-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21OH012114-01
Patents
No Patents information available for 1R21OH012114-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21OH012114-01
Clinical Studies
No Clinical Studies information available for 1R21OH012114-01
News and More
Related News Releases
No news release information available for 1R21OH012114-01
History
No Historical information available for 1R21OH012114-01
Similar Projects
No Similar Projects information available for 1R21OH012114-01